Provider Grand Rounds

1 Saint Anthonys Way,Alton IL 62002

28 September, 2021

Description

The Evolving Role of Cellular Therapy and Immunotherapy in Non-Hodgkin’s Lymphoma and Multiple Myeloma Presented by: Mark Fesler, M.D., Director, Blood and Marrow Transplant and Cellular Therapy Programs; Associate Professor, Department of Internal Medicine, Division of Hematology/Oncology, Saint Louis University School of Medicine Date: Tuesday, September 28, 2021 Time: 12:00 – 1:00 p.m. Lunch will be provided. Place: OSF Saint Anthony’s Health Center – Perpetual Help Center (PHC) Objectives: • Define cellular therapy and immunotherapy and understand their role for treatment in non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM) • Review the relevance of hematopoietic cell transplantation (HCT) for treatment of NHL and MM in the era of new cellular therapies and immunotherapies. • Understand the role of chimeric antigen receptor T-cell therapy (CAR-T) and other emerging cellular therapies in the treatment of NHL and MM. • Discuss the importance of continuum of care for patients receiving cellular therapy Provider Grand Rounds